drugset / Trial / NCT04185350

Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of Insulinoma

NCT04185350 ↗

NaSingle-groupOpen-labelDiagnostic

Summary

Glucagon-like peptide-1 receptor (GLP-1R) is a kind of G protein coupled receptor which regulate the insulin secretion and serves as potential target in the diagnosis of functional pancreas neuroendocrine tumor. The aim of this study was the clinical evaluation of a potential GLP-1R targeted tracer 68Ga-NOTA-MAL-Cys39-exendin-4 for the detection of insulinoma.

Timeline

Start
2019-05-05
Primary completion
2020-04-05
Completion
2020-05-05

Drugs

EvaluationDrugModalityDoseRoute
Subject 68Ga-NOTA-MAL-Cys39-exendin-4 Diagnostic / imaging agent 111 mbq Intravenous
Subject 68Ga-NOTA-MAL-Cys39-exendin-4 Diagnostic / imaging agent 185 mbq Intravenous

Indications